ACTA2-AS1 knockdown promotes liver cancer cell proliferation, migration and invasion (Zhou and Lv, 2019), while ACTA2-AS1 suppresses lung adenocarcinoma progression (Ying et al., 2020), implying an inhibitory effect on the two cancers. This evidence concerns the gene ACTA2 and lung adenocarcinoma.